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Summary
Background Information regarding association between 
cytomegalovirus (CMV) infection and essential hyper-
tension (EH) risk is not consistent across studies. There-
fore, we conducted a meta-analysis to investigate the 
association in detail.
Methods We comprehensively searched the pub-
lished literature from the PubMed and Embase databases 
for any study analyzing the association between CMV 
and EH risk. A random-effects model was used to cal-
culate the pooled odds ratio (OR) with 95 % confidence 
interval (CI).
Results Three studies involving 9657 patients were 
included in the meta-analysis, and the results showed a 
significantly increased risk of EH in patients with CMV 
infection. Overall, 79.3 % of the hypertension patients 
were CMV-positive, which was significantly higher than 
the percentage for controls (OR = 1.39, 95 % CI = 0.95–2.05, 
P = 0.017). There was significant heterogeneity among the 
studies included (I2 = 70.5 %). The funnel plot and Egger’s 
test also indicated no publication bias.
Conclusions The results showed a significant associa-
tion between CMV and EH, which indicates that CMV 
infection is a possible cause of EH.
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Background
Essential hypertension (EH) is the most common form 
of hypertension [1] and is a major risk factor for cardio-
vascular, cerebrovascular, and renal diseases. Hyperten-
sion is a multifactorial disease [2], and its development 
involves both genetic and environmental factors; how-
ever, the specific mechanism and risk factors remain 
unclear.
As a member of the human Herpesviridae family, cyto-
megalovirus (CMV) contains double-stranded DNA [3] 
and establishes a latent infection that can persist for the 
lifetime of the host. Despite being nearly ubiquitous in 
the population [4], overt human CMV disease in adults 
is typically restricted to immunocompromised individu-
als [5–7]. In healthy individuals, both primary infection 
and the reactivation of latent virus rarely cause any sig-
nificant clinical symptoms owing to the robust immune 
response of the host.
CMV infection is associated with various chronic 
inflammatory diseases, including cardiovascular dis-
eases (CVDs) [8] such as myocarditis, atherosclerosis, 
and coronary artery disease [9–11]. Hypertension is an 
important cause of CVDs, and recent studies [12–18] 
have shown that patients with a CMV infection have an 
increased risk of EH; however, the association between 
CMV and EH remains unclear, and thus the effect of CMV 
infection on blood pressure is controversial. Therefore, 
we performed the present meta-analysis to more com-
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prehensively investigate the association between CMV 
and EH.
Materials and methods
Literature search and selection
We comprehensively searched the PubMed and Embase 
databases up to July 2015. The search key words used 
included “EH or hypertension”, “blood pressure”, and 
“CMV”. Relevant articles in the reference lists of the pub-
lished literature were also searched manually for other 
potential studies.
Inclusion and exclusion criteria
Studies were included in the meta-analysis if they met 
the following criteria (1) case-control study, (2) investi-
gated the positive rate of CMV in hypertension patients 
and controls, (3) hypertension is defined as systolic blood 
pressure (SBP) or diastolic blood pressure (DBP) of 140 or 
90 mmHg, respectively, (4) not an animal study. Studies 
were excluded if insufficient details were reported to be 
able to perform the meta-analysis.
Data extraction
Two authors (JH and Y-YQ) extracted the data indepen-
dently. In cases where any data were lacking from an arti-
cle, the authors of selected studies were contacted directly 
for the missing data. The two reviewers came to an agree-
ment before the final analysis. The following information 
was extracted from each study: first author’s name, year of 
publication, country, ethnicity, CMV detection method, 
patient characteristics, the sample sizes of cases and con-
trols, and the relationship between CMV and EH.
Statistical analysis
We performed statistical analyses using Stata statistical 
software ver.12.0. (Stata Corporation, College Station, 
TX, USA). Meta-analysis was conducted by combining 
odds ratios (ORs) with corresponding 95 % confidence 
intervals (CIs) for the association between the CMV-posi-
tive rate of hypertension patients and controls. Heteroge-
neity across all selected studies was evaluated using the 
Q-test and the I2 statistic (range 0–100 %) [19] and was 
judged to be significant when P < 0.1 or I2 > 50 %, respec-
tively. We select the random-effects model in the analysis 
if significant heterogeneity was observed across studies; 
otherwise, the fixed-effects model was used. Sensitivity 
analysis was performed with the random-effects model 
to evaluate the stability of the crude results by removing 
one study at a time. The Begg’s funnel plot and Egger’s 
linear regression test were performed to determine the 
level of potential publication bias [20, 21]. A P-value 
lower than 0.05 was considered statistically significant.
Results
Characteristics of studies included
A total of three articles [12, 13, 16] were included in the 
meta-analysis, comprising 2347 cases and 7310 controls. 
All of the studies used enzyme-linked immunosorbent 
assay (ELISA), and one study [12] used a combination of 
ELISA and polymerase chain reaction (PCR). ELISA was 
used to determine the titer of anti-HCMV IgG antibodies, 
and quantitative PCR was used to test the HCMV DNA 
copy number. The flow diagram for the search process is 
shown in Fig. 1. The characteristics of the selected studies 
are given in Table 1.
Meta-analysis results
We pooled data from all studies included and analyzed 
the association between CMV and EH risk. A total of 
79.3 % of the hypertension patients were CMV-positive 
compared with 64.2 % of the controls. The pooled OR 
was 1.39 (95 % CI = 0.95–2.05, P = 0.017). We used a ran-
dom-effects model, given the significant heterogeneity 
(I2 = 70.5 %) observed across studies. The overall result of 
the meta-analysis is shown as a forest plot in Fig. 2.
Sensitivity analysis
Sensitivity analysis was conducted to evaluate the stabil-
ity of the crude results. The results showed that no sin-
gle study substantially affected the stability of the crude 
results, given the lack of change in the ORs after exclu-
sion of one study at a time (Fig. 3). Therefore, the results 
of this meta-analysis were deemed to be reliable.
Fig. 1 Flow diagram of the study selection process
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affecting the seropositivity [22] in most Asian countries 
that are still developing countries, especially China.
When a human is first infected, CMV replicates in 
many different cells. The virus can remain a latent state 
for the life of its host. In most immunocompetent indi-
viduals, the CMV infection is mild or even asymptomatic. 
Viruses modulate the intracellular environment so that it 
is optimized to support the viral life cycle. With height-
ened stress or immunosuppression, however, latent CMV 
can be reactivated reinitiating productive replication and 
causing clinical problems, especially in immunosup-
pressed or immunocompromised patients. Moreover, 
CMV infection has been shown to be associated with the 
increased arterial blood pressure via stimulation with 
renin and cytokine production in mice [23].
Recently, several previous studies have investigated 
the role of CMV seropositivity as a risk factor for hyper-
tension. In a Chinese cohort, Tang et al. [12]. showed 
that CMV seropositivity was significantly associated with 
hypertension after adjustment for age in Kazakh males 
but not in females. However, in another study cohort [13], 
CMV seropositivity was associated with hypertension in 
females before, but not after, adjusting for age. By con-
Publication bias
Begg’s funnel plot and Egger’s test were used to evaluate 
the potential publication bias. Although Begg’s funnel 
plot was not symmetrical, the Egger’s linear regression 
test indicated that there was no significant publication 
bias (Fig. 4; P = 0.361).
Discussion
CMV infection has been reported to be associated with 
hypertension [12–18]. Regardless of the approach used, 
both negative and positive associations have been 
reported; therefore, the role of CMV in hypertension 
remains controversial. Discrepancies between different 
studies might be due to differences in sample size, age, 
ethnicity, region, dietary habits, climate, lifestyles, and 
immune responses to CMV infection, among other fac-
tors. Besides, the seroprevalence is considerably high 
in China [12] to other evaluated studies’ countries, we 
believe that low socioeconomic status is also a factor 
Table 1 Details of studies included in the meta-analysis
Reference Year Ethnicity/Country CMV detection N Male (%) Cases (n = 2347) Controls 
(n = 7310)
Result
CMV+ CMV- CMV+ CMV-
[12] 2014 Han/China ELISA, PCR 800 42.8 433 49 288 30 CMV antibody titers associated 
with blood pressure and hyperten-
sion
Kazakh/China 800 42.0 452 15 311 22 CMV seropositivity associated with 
hypertension in males
[16] 2013 Iran ELISA 1754 49.2 442 17 1193 102 Pathogen burden not associated 
with hypertension
[13] 2012 USA ELISA 6303 47.3 534 405 2902 2462 CMV seropositivity associated with 
hypertension in women
ELSA enzyme-linked immunosorbent assay, PCR polymerase chain reaction, CMV cytomegalovirus
Fig. 2 Forest plot of the cy-
tomegalovirus (CMV)-positive 
rate in hypertension patients 
versus controls. OR odds 
ratio, CI confidence interval
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25]. Reactive oxygen species (ROS) have been shown to 
be generated in response to CMV infection [26] and are 
also directly involved in vasoconstriction [27–30] and 
vascular inflammation [31]. CMV infection can induce 
an inflammatory reaction through modulation of inflam-
matory mediators that evoke vasoconstriction, such as 
cytokines, chemokines, and adhesion molecules [32–34]. 
Second, CMV might influence hypertension via regula-
tion of the renin-angiotensin system. CMV infection has 
been shown to induce the generation of angiotensin II 
(AngII) [25], which reacts with endothelial nitric oxide 
synthase to promote vasoconstriction; this may also 
enhance the production of ROS [35, 36]. An in vivo exper-
imental study showed that CMV infection increased arte-
rial pressure and further stimulated the expression of 
renin and increased AngII levels in the blood and arte-
rial tissues [23], which can lead to arterial constriction. 
Third, the immune response triggered by CMV infection 
could itself lead to hypertension. Indeed, suppression 
of the immune system has been shown to depress blood 
pressure in both experimental animals and humans [37]. 
Finally, genomic-related changes could be involved in 
the mechanism. In particular, DNA methylation of gene 
promoter region [38–40] and the corresponding changes 
in mRNA expression [14] are also involved in regulating 
blood pressure. The studies included there are not 
enough, so we need more prospective studies to prove 
the link.
The results of the present meta-analysis suggest that 
CMV may be a contributing factor to the development of 
EH. However, there are limitations to the meta-analysis 
that should be acknowledged. First, although the pooled 
sample size of the studies included was sufficiently large 
to carry out the meta-analysis, the number of studies 
included is not as large as we had hoped for in order to 
perform a comprehensive analysis. In particular, this 
limited our ability to conduct a subgroup analysis to 
explore the influence of sample size, ethnicity, age, or 
other factors and to explore the nature of the observed 
heterogeneity. Therefore, these findings should be inter-
preted with caution, and more studies are needed to con-
firm the results of this meta-analysis.
Conclusions
The results showed a significant association between 
CMV and EH, which indicates that CMV infection is a 
possible cause of EH.
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trast, another study in a Chinese cohort [14] showed that 
plasma CMV deoxyribonucleic acid (DNA) copy number 
was associated with hypertension.
Few studies have examined the CMV antibody titer as 
a risk factor for hypertension. One study [15] showed that 
CMV antibody titers were independent determinants 
for SBP and DBP elevation in young males but not in 
females. By contrast, Tang et al. [12] demonstrated that, 
in both Han Chinese males and females, CMV antibody 
titers were significantly independently associated with 
hypertension. However, Vahdat et al. [16] failed to show 
any significant association between viral infections and 
hypertension in patients from Iran.
In this meta-analysis, we selected three studies [12, 
13, 16], including 2347 cases and 7310 controls; all the 
studies included were population-based cross-sectional 
studies. We constructed a forest plot to obtain the pooled 
OR and demonstrated that patients with CMV infection 
showed a higher risk of EH. Although the mechanism 
underlying how CMV might cause EH remains unclear, 
there are several possible explanations for this link. First, 
oxidative stress and inflammation might play a role [24, 
Fig. 4 Funnel plot to evaluate potential publication bias in 
studies evaluating the association between cytomegalovirus 
(CMV) and essential hypertension risk
 
Fig. 3 Sensitivity analysis
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